Semaglutide Improves Intestinal Barrier Function in T2D—A Double-Blind Randomized Controlled Trial (RCT)

Related

• Semaglutide may protect kidneys by reducing vascular resistance

  Nature Medicine · 4 Oct 2026

  

• Survodutide reduces weight in adults with diabetes and obesity

  The New England Journal of Medicine · 4 Oct 2026

• A triple-target drug cut body weight by up to 19.7% in a trial

  Cell Metabolism · 8 Oct 2026

• Semaglutide improved heart artery function in pigs

  Research Square · 8 Oct 2026